106 related articles for article (PubMed ID: 36007676)
1. Mechanism of apoptosis activation by Curcumin rescued mutant p53Y220C in human pancreatic cancer.
Malhotra L; Sharma S; Hariprasad G; Dhingra R; Mishra V; Sharma RS; Kaur P; Ethayathulla AS
Biochim Biophys Acta Mol Cell Res; 2022 Dec; 1869(12):119343. PubMed ID: 36007676
[TBL] [Abstract][Full Text] [Related]
2. Curcumin rescue p53Y220C in BxPC-3 pancreatic adenocarcinomas cell line: Evidence-based on computational, biophysical, and in vivo studies.
Malhotra L; Goyal HKV; Jhuria S; Dev K; Kumar S; Kumar M; Kaur P; Ethayathulla AS
Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129807. PubMed ID: 33278547
[TBL] [Abstract][Full Text] [Related]
3. Flavonoids as potential reactivators of structural mutation p53Y220C by computational and cell-based studies.
Malhotra L; Kaur P; Ethayathulla AS
J Biomol Struct Dyn; 2023 Aug; ():1-12. PubMed ID: 37643005
[TBL] [Abstract][Full Text] [Related]
4. Enhanced phosphorylation of p53 by microRNA-26a leading to growth inhibition of pancreatic cancer.
Batchu RB; Gruzdyn OV; Qazi AM; Kaur J; Mahmud EM; Weaver DW; Gruber SA
Surgery; 2015 Oct; 158(4):981-6; discussion 986-7. PubMed ID: 26189069
[TBL] [Abstract][Full Text] [Related]
5. Curcumin mediates selective aggregation of mutant p53 in cancer cells: A promising therapeutic strategy.
Oak S; Karajgikar O; Teni T
Biochem Biophys Res Commun; 2023 Oct; 677():141-148. PubMed ID: 37586212
[TBL] [Abstract][Full Text] [Related]
6. Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53.
Kabir M; Sun N; Hu X; Martin TC; Yi J; Zhong Y; Xiong Y; Kaniskan HÜ; Gu W; Parsons R; Jin J
J Am Chem Soc; 2023 Jul; 145(27):14932-14944. PubMed ID: 37365684
[TBL] [Abstract][Full Text] [Related]
7. A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status.
Garufi A; Baldari S; Pettinari R; Gilardini Montani MS; D'Orazi V; Pistritto G; Crispini A; Giorno E; Toietta G; Marchetti F; Cirone M; D'Orazi G
J Exp Clin Cancer Res; 2020 Jun; 39(1):122. PubMed ID: 32605658
[TBL] [Abstract][Full Text] [Related]
8. Evidence for activation of mutated p53 by apigenin in human pancreatic cancer.
King JC; Lu QY; Li G; Moro A; Takahashi H; Chen M; Go VL; Reber HA; Eibl G; Hines OJ
Biochim Biophys Acta; 2012 Feb; 1823(2):593-604. PubMed ID: 22227579
[TBL] [Abstract][Full Text] [Related]
9. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells.
Sahu RP; Batra S; Srivastava SK
Br J Cancer; 2009 May; 100(9):1425-33. PubMed ID: 19401701
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments].
Bouvet M; Bold RJ; Lee J; Evans DB; Abbruzzese JL; Chiao PJ; McConkey DJ; Chandra J; Chada S; Fang B; Roth JA
Ann Surg Oncol; 1998 Dec; 5(8):681-8. PubMed ID: 9869513
[TBL] [Abstract][Full Text] [Related]
11. Anti-proliferative and apoptotic effect of gemini curcumin in p53-wild type and p53-mutant colorectal cancer cell lines.
Ebrahimi M; Babaei E; Neri F; Feizi MAH
Int J Pharm; 2021 May; 601():120592. PubMed ID: 33857585
[TBL] [Abstract][Full Text] [Related]
12. MDM2 inhibitor MI-319 in combination with cisplatin is an effective treatment for pancreatic cancer independent of p53 function.
Azmi AS; Aboukameel A; Banerjee S; Wang Z; Mohammad M; Wu J; Wang S; Yang D; Philip PA; Sarkar FH; Mohammad RM
Eur J Cancer; 2010 Apr; 46(6):1122-31. PubMed ID: 20156675
[TBL] [Abstract][Full Text] [Related]
13. Degradation of mutant p53H175 protein by Zn(II) through autophagy.
Garufi A; Pucci D; D'Orazi V; Cirone M; Bossi G; Avantaggiati ML; D'Orazi G
Cell Death Dis; 2014 May; 5(5):e1271. PubMed ID: 24874727
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells.
Collins HM; Abdelghany MK; Messmer M; Yue B; Deeves SE; Kindle KB; Mantelingu K; Aslam A; Winkler GS; Kundu TK; Heery DM
BMC Cancer; 2013 Jan; 13():37. PubMed ID: 23356739
[TBL] [Abstract][Full Text] [Related]
15. The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53.
Madan E; Parker TM; Bauer MR; Dhiman A; Pelham CJ; Nagane M; Kuppusamy ML; Holmes M; Holmes TR; Shaik K; Shee K; Kiparoidze S; Smith SD; Park YA; Gomm JJ; Jones LJ; Tomás AR; Cunha AC; Selvendiran K; Hansen LA; Fersht AR; Hideg K; Gogna R; Kuppusamy P
J Biol Chem; 2018 Mar; 293(12):4262-4276. PubMed ID: 29382728
[TBL] [Abstract][Full Text] [Related]
16. [DLys(6)]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo.
Aggarwal S; Ndinguri MW; Solipuram R; Wakamatsu N; Hammer RP; Ingram D; Hansel W
Int J Cancer; 2011 Oct; 129(7):1611-23. PubMed ID: 21484797
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative and Apoptotic Effect of Dendrosomal Curcumin Nanoformulation in P53 Mutant and Wide-Type Cancer Cell Lines.
Montazeri M; Pilehvar-Soltanahmadi Y; Mohaghegh M; Panahi A; Khodi S; Zarghami N; Sadeghizadeh M
Anticancer Agents Med Chem; 2017; 17(5):662-673. PubMed ID: 27604683
[TBL] [Abstract][Full Text] [Related]
18. Anacardic acid inhibits pancreatic cancer cell growth, and potentiates chemotherapeutic effect by Chmp1A - ATM - p53 signaling pathway.
Park M; Upton D; Blackmon M; Dixon V; Craver S; Neal D; Perkins D
BMC Complement Altern Med; 2018 Feb; 18(1):71. PubMed ID: 29463243
[TBL] [Abstract][Full Text] [Related]
19. New orally active DNA minor groove binding small molecule CT-1 acts against breast cancer by targeting tumor DNA damage leading to p53-dependent apoptosis.
Saini KS; Hamidullah ; Ashraf R; Mandalapu D; Das S; Siddiqui MQ; Dwivedi S; Sarkar J; Sharma VL; Konwar R
Mol Carcinog; 2017 Apr; 56(4):1266-1280. PubMed ID: 27813185
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
